Weber WA - Search Results

1

Repeatability of 18F-FDG uptake measurements in tumors: a metaanalysis.

de Langen AJ, Vincent A, Velasquez LM, van Tinteren H, Boellaard R, Shankar LK, Boers M, Smit EF, Stroobants S, Weber WA, Hoekstra OS. de Langen AJ, et al. Among authors: weber wa. J Nucl Med. 2012 May;53(5):701-8. doi: 10.2967/jnumed.111.095299. Epub 2012 Apr 10. J Nucl Med. 2012. PMID: 22496583 Free article.

2

Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.

Weber W, Bartenstein P, Gross MW, Kinzel D, Daschner H, Feldmann HJ, Reidel G, Ziegler SI, Lumenta C, Molls M, Schwaiger M. Weber W, et al. J Nucl Med. 1997 May;38(5):802-8. J Nucl Med. 1997. PMID: 9170450 Free article.

3

Breast imaging with fluorine-18-FDG PET: quantitative image analysis.

Avril N, Bense S, Ziegler SI, Dose J, Weber W, Laubenbacher C, Römer W, Jänicke F, Schwaiger M. Avril N, et al. J Nucl Med. 1997 Aug;38(8):1186-91. J Nucl Med. 1997. PMID: 9255146 Free article.

4

Assessment of pulmonary lesions with 18F-fluorodeoxyglucose positron imaging using coincidence mode gamma cameras.

Weber W, Young C, Abdel-Dayem HM, Sfakianakis G, Weir GJ, Swaney CM, Gates M, Stokkel MP, Parker A, Hines H, Khanvali B, Liebig JR, Leung AN, Sollitto R, Caputo G, Wagner HN Jr. Weber W, et al. J Nucl Med. 1999 Apr;40(4):574-8. J Nucl Med. 1999. PMID: 10210215 Free article. Clinical Trial.

5

18F-FDG PET studies in patients with extratemporal and temporal epilepsy: evaluation of an observer-independent analysis.

Drzezga A, Arnold S, Minoshima S, Noachtar S, Szecsi J, Winkler P, Römer W, Tatsch K, Weber W, Bartenstein P. Drzezga A, et al. J Nucl Med. 1999 May;40(5):737-46. J Nucl Med. 1999. PMID: 10319744 Free article.

6

Reproducibility of metabolic measurements in malignant tumors using FDG PET.

Weber WA, Ziegler SI, Thödtmann R, Hanauske AR, Schwaiger M. Weber WA, et al. J Nucl Med. 1999 Nov;40(11):1771-7. J Nucl Med. 1999. PMID: 10565769 Free article. Clinical Trial.

7

Quantitative assessment of tumor metabolism using FDG-PET imaging.

Weber WA, Schwaiger M, Avril N. Weber WA, et al. Nucl Med Biol. 2000 Oct;27(7):683-7. doi: 10.1016/s0969-8051(00)00141-4. Nucl Med Biol. 2000. PMID: 11091112 Review.

8

Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.

Avril N, Menzel M, Dose J, Schelling M, Weber W, Jänicke F, Nathrath W, Schwaiger M. Avril N, et al. J Nucl Med. 2001 Jan;42(1):9-16. J Nucl Med. 2001. PMID: 11197987 Free article.

9

Monitoring antiproliferative responses to kinase inhibitor therapy in mice with 3'-deoxy-3'-18F-fluorothymidine PET.

Waldherr C, Mellinghoff IK, Tran C, Halpern BS, Rozengurt N, Safaei A, Weber WA, Stout D, Satyamurthy N, Barrio J, Phelps ME, Silverman DH, Sawyers CL, Czernin J. Waldherr C, et al. Among authors: weber wa. J Nucl Med. 2005 Jan;46(1):114-20. J Nucl Med. 2005. PMID: 15632041 Free article.

10

Comparison between 18F-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent colorectal cancer.

Kim JH, Czernin J, Allen-Auerbach MS, Halpern BS, Fueger BJ, Hecht JR, Ratib O, Phelps ME, Weber WA. Kim JH, et al. Among authors: weber wa. J Nucl Med. 2005 Apr;46(4):587-95. J Nucl Med. 2005. PMID: 15809480 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

380 results

Search Page

Filters